Last reviewed · How we verify

Dexpanthenol foam spray, new formulation — Competitive Intelligence Brief

Dexpanthenol foam spray, new formulation (Dexpanthenol foam spray, new formulation) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin B5 derivative. Area: Dermatology.

phase 2 Vitamin B5 derivative Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Dexpanthenol foam spray, new formulation (Dexpanthenol foam spray, new formulation) — Bayer. Dexpanthenol, a form of vitamin B5, helps to soothe and protect the skin by promoting the healing of wounds and reducing inflammation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dexpanthenol foam spray, new formulation TARGET Dexpanthenol foam spray, new formulation Bayer phase 2 Vitamin B5 derivative

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin B5 derivative class)

  1. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dexpanthenol foam spray, new formulation — Competitive Intelligence Brief. https://druglandscape.com/ci/dexpanthenol-foam-spray-new-formulation. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: